CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 26 enrolled
Drug / intervention
Endoscopic Release +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03883477
NCT03883477N/ACompleted
CompareCT.gov

Endoscopic Trigger Finger Release

Cedars-Sinai Medical Center·interventional·Posted Mar 21, 2019·Updated May 11, 2022

In Brief

A clinical study evaluating Endoscopic Release and Standard Open Release for Trigger Finger. Completed, enrolled 26 participants across 1 site.

Detailed Summary

The purpose of this study is to compare recovery, scar, and patient satisfaction after retrograde endoscopic trigger finger release versus the standard open surgical treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTrigger Finger
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 21, 2019
Enrollment StartMar 13, 2019
Primary CompletionSep 24, 2021
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 7.3 years ago

Interventions

Endoscopic Releasedevice

Retrograde endoscopic release of the A1 pulley for treatment of trigger finger will be performed using a commercially available device by A.M. Surgical, Inc. This device has been cleared for marketing, sale and use by the U.S. Food and Drug Administration (FDA) for use as an Orthopedic manual surgical instrument based on its similarity in structure and function to previously used devices.

Standard Open Releaseprocedure

Standard open surgical release of the A1 pulley for treatment of trigger finger.